Guidelines Archive
Thursday, February 29, 2024
Wednesday, December 20, 2023
Thursday, November 2, 2023
Tuesday, October 10, 2023
Friday, July 21, 2023
Thursday, April 20, 2023
Monday, March 6, 2023
Monday, January 30, 2023
Thursday, January 26, 2023
Tuesday, January 10, 2023
Wednesday, December 28, 2022
Tuesday, December 6, 2022
Thursday, December 1, 2022
Thursday, November 10, 2022
Wednesday, October 19, 2022
Friday, September 30, 2022
Monday, September 26, 2022
Thursday, August 18, 2022
Monday, August 8, 2022
Tuesday, May 31, 2022
Friday, May 13, 2022
Friday, April 29, 2022
Friday, April 8, 2022
Friday, April 1, 2022
Thursday, March 24, 2022
Wednesday, March 2, 2022
Thursday, February 24, 2022
Tuesday, February 1, 2022
Wednesday, January 19, 2022
Wednesday, January 5, 2022
Thursday, December 30, 2021
- Full Guideline
- Statement on Paxlovid Drug-Drug Interactions
- Statement on Therapies for High-Risk, Nonhospitalized Patients With Mild to Moderate COVID-19
Thursday, December 23, 2021
- Full Guideline
- Statement on Anti-SARS-CoV-2 mAbs and RDV and Omicron
- Statement on Patient Prioritization for Outpatient Therapies
Thursday, December 16, 2021
Wednesday, October 27, 2021
Tuesday, October 19, 2021
Thursday, October 7, 2021
Wednesday, September 29, 2021
Wednesday, September 15, 2021
- Full Guideline
- Statement on Bamlanivimab Plus Etesevimab for the Treatment of Mild to Moderate COVID-19